Healthcare >> CEO Interviews >> October 17, 2003
DR. RAYMOND P. WARRELL JR. is Chairman of the Board and Chief Executive
Officer of Genta Incorporated. Dr. Warrell is internationally known for
his expertise in the clinical development of anticancer therapeutics.
Prior to his appointment at Genta he was Associate Physician-in-Chief
and tenured Member of the Memorial Sloan-Kettering Cancer Center. He was
also Professor of Medicine at the Joan and Sanford Weill Medical College
of Cornell University. He has been a consultant to a number of
pharmaceutical and biotechnology companies, including Genta. He is a co-
Founder of PolaRx Biopharmaceuticals, Inc. (which developed arsenic
trioxide (Trisenox) for the treatment of acute promyelocytic leukemia)
and also of Relgen LLC, a privately held pharmaceutical company. Dr.
Warrell holds numerous patents for biomedical therapeutic and diagnostic
agents. He has published more than 300 scientific papers, book chapters
and abstracts, primarily related to treatment of cancer and bone
disease. He is a graduate of Emory University (BS in Chemistry), the
Medical College of Georgia (MD), and Columbia University School of
Business (MBA). Profile
Dr. Warrell: Genta, which has been in business for 15 years, is a
biopharmaceutical company focused on the development of innovative
